Epstein-Barr viral gene expression in B-lymphocytes

Leukemia and Lymphoma

Volumn 30, Issue 1-2, 1998, Pages 123-129

  Schwarzmann, Fritz ^a   Jäger, Michael ^a   Hornef, Mathias ^b   Prang, Nadja ^c   Wolf, Hans ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c Medizinisch Immunologische L   (Germany)

Author keywords

B lymphocytes; Chronic; Epstein Barr virus; Latency

Indexed keywords

ARTICLE; B LYMPHOCYTE; CYTOLYSIS; EPITHELIUM CELL; EPSTEIN BARR VIRUS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSURVEILLANCE; MONONUCLEOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; TISSUE DIFFERENTIATION; VIRUS GENE; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0031868795     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809050935     Document Type: Article

References (43)

1. Henle, G., Henle, W. and Diehl, V. (1968). Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci U S A, 59, 94-101.
2. Sixbey, J. W., Nedrud J. G., Raab Traub, N., Hanes, R. A. and Pagano, J. S. (1984). Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med, 310, 1225-1230.
3. Sixbey, J. W., Vesterinen, E. H., Nedrud, J. G., Raab Traub, N., Walton, L. A. and Pagano, J. S. (1983). Replication of Epstein-Barr virus in human epithelial cells infected in vitro. Nature, 306, 480-483.
4. Becker, J., Leser, U., Marschall, M., Langford, A., Jilg, W., Gelderblom, H., Reichart, P. and Wolf, H. (1991). Expression of proteins encoded by Esptein-Barr virus transactivator genes depends on the differentiation of epithelial cells in oral hairy leukoplakia. Proc Natl Acad Sci U S A, 88, 8332-8336.
5. Sandvej, K., Krenacs, L., Hamilton Dutoit, S. J., Rindum, J. L., Pindborg, J. J. and Pallesen, G. (1992). Epstein-Barr virus latent and replicative gene expression in oral hairy leukoplakia. Histopatholagy, 20, 387-395.
6. Young, L. S., Lau, R., Rowe, M., Niedobitek, G., Packham, G., Shanahan, F., Rowe, D. T., Greenspan, D., Rickinson, A. B. and Fareil, P. J. (1991). Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J Virol, 65, 2868-2874.
7. Anagnostopoulos, I., Hummel, M., Kreschel, C. and Stein, H. (1995). Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood, 85, 744-750.
8. Tao, Q., Srivastava, G., Chan, A. C., Chung, L. P., Loke, S. L. and Ho, F. C. (1995). Evidence for lytic infection by Epstein-Barr virus in mucosal lymphocytes instead of nasopharyngeal epithelial cells in normal individuals. J Med Virol, 45, 71-77.
9. Tierney, R, J., Steven, N., Young, L. S. and Rickinson, A. B. (1994). Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Viral, 68, 7374-7385.
10. Miyashita, E. M., Yang, B., Lam, K. M., Crawford, D. H. and Thorley Lawson, D. A. (1995). A novel form of Epstein-Barr virus latency in normal B-cells in vivo. Cell, 80, 593-601.
11. Decker, L. L., Klamen, L. D. and Thorky-Lawson, D. A. (1996). Detection of the Latent Form of Epstein-Barr Virus DNA in the Peripheral Blood of Healthy Individuals. J Virol, 70, 3286-3289.
12. Prang, N. S., Hornef, M. W., Jäger, M., Wagner, W. J., Wolf, H. and Schwarzmann, F.(1997). Lytic replication of Epstein-Barr virus in the peripheral blood: Analysis of viral gene expression in B-lymphocytes during infectious mononucleosis and in the normal carrier state. Blood, 89, 1665-1677.
13. Yao, Q. Y., Rickinson, A. B. and Epstein, M. A. (1985). A reexamination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int J Cancer, 35, 35-42.
14. Yao, Q. Y., Rickinson, A. B. and Epstein, M. A. (1985). Oropharyngeal shedding of infectious Epstein-Barr virus in healthy virus-immune donors. A prospective study. Chin Med J Engl, 98, 191-196.
15. Jäger, M., Prang, N., Mitterer, M., Larcher, C., Huemer, H. P., Reischl, U., Wolf, H. and Schwarzmann, F. (1996). Pathogenesis of chronic Epstein-Barr virus infection: detection of a virus strain with a high rate of lytic replication. Br J Haematol, 95, 626-636.
16. Gratama, J. W., Oosterveer, M. A., Zwaan, F. E., Lepoutre, J., Klein, G. and Ernberg, I. (1988). Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proc Natl Acad Sci U S A, 85, 8693-8696.
17. Nemerow, G. R., Mullen, J. J., Dickson, P. W. and Cooper, N. R. (1993). Soluble recombinant CR2 (CD21) inhibits Epstein-Barr virus infection. J Virol, 64, 1348-1352.
18. Fingeroth, J. D., Weis, J. J., Tedder, T. F., Strominger, J. L., Biro, P. A. and Fearon, D. T. (1984). Epstein-Barr virus receptor of human B-lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci USA, 81, 4510-4514.
19. Fischer, E., Delibrias, C. and Kazatchkine, M. D. (1991). Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T-lymphocytes. J Immunol, 146, 865-869.
20. Bayliss, G. and Wolf, H. (1981). An Epstein-Barr virus early protein induced cell fusion. Proc Natl Acad Sci USA, 78, 7162-7165.
21. Bayliss, G. J. and Wolf, H. (1980). Epstein-Barr virus-induced cell fusion. Nature, 287, 164-165.
22. Sixbey, J. W. and Yao, Q. Y. (1992). Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science, 255, 1578-1580.
23. Sixbey, J. W., Lemon, S. M. and Pagano, J. S. (1986). A second site for Epstein-Barr virus shedding: The uterine cervix. The Lancet, 2, 1122-1124.
24. Kobayashi, R., Takeuchi, H., Sasaki, M., Hasegawa, M. and Hirai, K. (1994). Detection of Epstein-Barr virus infection in the epithelial cells of lymphocytes and non-neoplastic tonsils by in situ hybridisation and RT-PCR. Epstein-Barr virus & associated diseases, CSH, 7-11 September, 1994. 89.
25. Wolf, H., Haus, M. and Wilmes, E. (1984). Persistence of Epstein-Barr virus in the parotid gland. J Virol, 51, 795-798.
26. Sam, C. K., Brooks, L. A., Niedobitek, G., Young, L. S., Prasad, U. and Rickinson, A. B. (1993). Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinoma. Int J Cancer, 53, 957-962.
27. Bogedain, C., Wolf, H., Modrow, S., Stuber, G. and Jilg, W. (1995). Specific cytotoxic T-lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus. J Virol, 69, 4872-4879.
28. Chen, H. L., Lung, M. L., Chan, K. H., Griffin, B. E. and Ng, M. H. (1996). Tissue distribution of Epstein-Barr virus genotypes. J Virol, 70, 7301-7305.
29. Okano, M., Matsumoto, S., Osato, T., Sakiyama, Y., Thiele, G. M. and Purtilo, D. T. (1991). Severe chronic active Epstein-Barr virus infection syndrome. Clin Microbiol Rev, 4, 129-135.
30. Jones, J. F. and Straus, S. E. (1987). Chronic Epstein-Barr virus infection. Anna Rev Med, 195-209.
31. Okano, M., Thiele, G. M., Davis, J. R., Grierson, H. L. and Purtilo, D. T. (1988). Epstein-Barr virus and human diseases: recent advances in diagnosis. Clin Microbiol Rev, 1, 300-312.
32. Mitterer, M., Pescosta, N., Fend, F., Larcher, C., Prang, N., Schwarzmann, F., Coser, P. and Huemer, H. P. (1995). Chronic active Epstein-Barr virus disease in a case of persistent polyclonal B-cell lymphocytosis. Br J Haematol, 90, 526-531.
33. Larcher, C., Fend, F., Mitterer, M., Prang, N., Schwarzmann, F. and Huemer, H. P. (1995). Role of Epstein-Barr virus and soluble CD21 in persistent polyclonal B-cell lymphocytosis. Br J Haematol, 90, 532-540.
34. Alfieri, C. and Joncas, J. H.(1987). Biomolecular analysis of a defective nontransforming Epstein- Barr virus (EBV) from a patient with chronic active EBV infection. J Virol, 61, 3306-3309.
35. Alfieri, C., Ghibu, F. and Joncas, J. H. (1984). Lytic, non-transforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection. Can Med Assoc J, 131, 1249-1252.
36. Borysiewicz, L. K., Haworth, S. J., Cohen, J., Mundin, J., Rickinson, A. and Sissons, J. G. (1986). Epstein-Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis. Exp Cell Res., 58, 111-121.
37. Fujieda, M., Wakiguchi, H., Hisakawa, H. Kubota, H. and Kurashige, T. (1993). Defective activity of Epstein-Barr virus (EBV) specific cytotoxic T-lymphocytes in children with chronic active EBV infection and in their parents. Acta Paediatr Jpn, 35, 394-399.
38. Joncas, J., Monczak, Y., Ghibu, F., Alfieri, C., Bonin, A., Ahronheim, G. and Rivard, G. (1989). Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection. J Med Virol, 28, 110-117.
39. Kibler, R., Lucas, D. O., Hicks, M. J., Poulos, B. T. and Jones, J. F. (1985). Immune function in chronic active Epstein-Barr virus infection. J Clin Immunol, 5, 46-54.
40. Kuis, W.,Roord, J. J., Zegers, B. J., Rickinson, A. B., Kapsenberg, J. G., The, H. and Stoop, J. W. (1985). Heterogeneity of immune defects in three children with a chronic active Epstein-Barr virus infection. J Clin Immunol, 5, 377-385.
41. Tosato, G., Straus, S., Henle, W., Pike, S. E. and Blaese, R. M. (1985). Characteristic T-cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). J Immunol, 134, 3082-3088.
42. Kenney, S. and Zalani, S. (1995). Regulation of BZLF1 function by viral and host cell factors. Epstein-Barr Virus Report, 2, 23-28.
43. Prang, N., Wolf, H. and Schwarzmann, F. (1995). Epstein-Barr virus lytic replication is controlled by a posttranscriptional mechanism of BZLF1. J Viral, 69, 2644-2648.